Wells Fargo & Company Cor Medix Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Cor Medix Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 19,266 shares of CRMD stock, worth $157,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,266

Previous 19,482 1.11%

Holding current value

$157,595

Previous $84,000 84.52%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.64 - $8.23 $786 - $1,777	-216 Reduced 1.11%	19,266 $155,000
Q2 2024 Aug 13, 2024	BUY	$4.08 - $6.39 $6,124 - $9,591	1,501 Added 8.35%	19,482 $84,000
Q1 2024 May 10, 2024	BUY	$2.94 - $4.24 $6,535 - $9,425	2,223 Added 14.11%	17,981 $76,000
Q4 2023 Feb 09, 2024	BUY	$3.0 - $4.01 $11,889 - $15,891	3,963 Added 33.6%	15,758 $59,000
Q3 2023 Nov 13, 2023	SELL	$3.6 - $4.46 $28,350 - $35,122	-7,875 Reduced 40.04%	11,795 $43,000
Q2 2023 Aug 15, 2023	BUY	$3.94 - $5.8 $71,782 - $105,670	18,219 Added 1255.62%	19,670 $77,000
Q1 2023 May 12, 2023	SELL	$3.22 - $4.61 $19,307 - $27,641	-5,996 Reduced 80.52%	1,451 $6,000
Q4 2022 Feb 13, 2023	BUY	$2.81 - $4.45 $22 - $35	8 Added 0.11%	7,447 $31,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $16,959 - $45,225	6,014 Added 422.04%	7,439 $21,000
Q2 2022 Aug 12, 2022	SELL	$2.73 - $5.61 $21,067 - $43,292	-7,717 Reduced 84.41%	1,425 $5,000
Q1 2022 May 16, 2022	SELL	$3.83 - $6.24 $51,892 - $84,545	-13,549 Reduced 59.71%	9,142 $50,000
Q4 2021 Feb 14, 2022	BUY	$4.47 - $5.56 $98,205 - $122,153	21,970 Added 3047.16%	22,691 $104,000
Q3 2021 Nov 15, 2021	SELL	$4.46 - $7.11 $651 - $1,038	-146 Reduced 16.84%	721 $4,000
Q2 2021 Aug 16, 2021	SELL	$6.05 - $10.09 $64,474 - $107,529	-10,657 Reduced 92.48%	867 $5,000
Q1 2021 May 13, 2021	SELL	$6.84 - $17.58 $166,854 - $428,846	-24,394 Reduced 67.92%	11,524 $116,000
Q4 2020 Feb 09, 2021	BUY	$5.0 - $9.15 $46,605 - $85,287	9,321 Added 35.05%	35,918 $266,000
Q3 2020 Nov 05, 2020	SELL	$3.96 - $6.15 $21,875 - $33,972	-5,524 Reduced 17.2%	26,597 $160,000
Q2 2020 Aug 13, 2020	SELL	$3.08 - $6.56 $27,014 - $57,537	-8,771 Reduced 21.45%	32,121 $202,000
Q1 2020 May 14, 2020	BUY	$2.35 - $7.08 $96,096 - $289,515	40,892 New	40,892 $147,000

Others Institutions Holding CRMD

# of Institutions

105

Shares Held

17.4M

Call Options Held

134K

Put Options Held

441K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $337M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cor Medix Inc. Transaction History